Access to anti-retroviral drugs, female in Côte d'Ivoire
Côte d'Ivoire: Access to anti-retroviral drugs, female was 84.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in Côte d'Ivoire, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
In 2024, access to anti-retroviral drugs, female in Côte d'Ivoire stood at 84.0%. That is the highest value across all 25 years on record.
That represents a change of up 3.7% on the previous year and up 140.0% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Côte d'Ivoire peaked at 84.0% in 2024 and was at its lowest, 0.0%, in 2000.
Côte d'Ivoire ranks 50th of 141 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female in Côte d'Ivoire, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 1.0% | — |
| 2005 | 4.0% | +300.0% |
| 2006 | 6.0% | +50.0% |
| 2007 | 8.0% | +33.3% |
| 2008 | 12.0% | +50.0% |
| 2009 | 17.0% | +41.7% |
| 2010 | 19.0% | +11.8% |
| 2011 | 23.0% | +21.1% |
| 2012 | 26.0% | +13.0% |
| 2013 | 29.0% | +11.5% |
| 2014 | 35.0% | +20.7% |
| 2015 | 40.0% | +14.3% |
| 2016 | 49.0% | +22.5% |
| 2017 | 60.0% | +22.4% |
| 2018 | 66.0% | +10.0% |
| 2019 | 69.0% | +4.5% |
| 2020 | 73.0% | +5.8% |
| 2021 | 76.0% | +4.1% |
| 2022 | 77.0% | +1.3% |
| 2023 | 81.0% | +5.2% |
| 2024 | 84.0% | +3.7% |
Côte d'Ivoire compared with similar countries
- Côte d'Ivoire's 84.0% is above the median for lower middle income countries, which is 80.0%, 1.1× the median. (39 countries reporting)
- Côte d'Ivoire's 84.0% is below the median for Sub-Saharan Africa, which is 88.5%, 95% of the median. (44 countries reporting)
Biggest year-on-year movements
Years where Access to anti-retroviral drugs, female in Côte d'Ivoire changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2005 | +300.0% | 1.0% | 4.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 4.8% | 0.0% | 17.0% | 10 |
| 2010s | 41.6% | 19.0% | 69.0% | 10 |
| 2020s | 78.2% | 73.0% | 84.0% | 5 |
Countries ranked near Côte d'Ivoire
More gender data for Côte d'Ivoire
- Child population (UN estimates and projections) 14,048 (2030)
- Child population (UN estimates and projections) (0-14), annual growth 0.858 % change on previous year (2030)
- Population 22,651 (2030)
- Working-age population (UN estimates and projections) 22,651 (2030)
- Population (UN estimates and projections), annual growth rate 3.17 % change on previous year (2030)
- Age population, age 00, female, interpolated 481,925 (2025)
- Age population, age 00, male, interpolated 491,308 (2025)
- Age population, age 01, female, interpolated 470,556 (2025)
- Age population, age 01, male, interpolated 477,925 (2025)
- Age population, age 02, female, interpolated 463,095 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Côte d'Ivoire?
- Access to anti-retroviral drugs, female in Côte d'Ivoire was 84.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Côte d'Ivoire?
- The highest recorded value was 84.0% in 2024.
- What is the lowest access to anti-retroviral drugs, female recorded in Côte d'Ivoire?
- The lowest recorded value was 0.0% in 2000.
- How does Côte d'Ivoire rank for access to anti-retroviral drugs, female?
- Côte d'Ivoire ranks 50th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Côte d'Ivoire?
- Over the last ten years it is up 140.0%. The long-run trend across the full record is volatile.
- Where does this Côte d'Ivoire data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.